Abstract:Abstract Background MicroRNAs (miRNAs), some of which function as oncogenes or tumor suppressor genes, are involved in carcinogenesis via regulating cell proliferation and/or cell death. MicroRNA miR-34 was recently found to be a direct target of p53, functioning downstream of the p53 pathway as a tumor suppressor. miR-34 targets Notch, HMGA2, and Bcl-2, genes involved in the self-renewal and survival of cancer stem cells. The role of miR-34 in gastric cancer has not been reported previously. In this study, we examined the effects of miR-34 restoration on p53-mutant human gastric cancer cells and potential target gene expression. Methods Human gastric cancer cells were transfected with miR-34 mimics or infected with the lentiviral miR-34-MIF expression system, and validated by miR-34 reporter assay using Bcl-2 3'UTR reporter. Potential target gene expression was assessed by Western blot for proteins, and by quantitative real-time RT-PCR for mRNAs. The effects of miR-34 restoration were assessed by cell growth assay, cell cycle analysis, caspase-3 activation, and cytotoxicity assay, as well as by tumorsphere formation and growth. Results Human gastric cancer Kato III cells with miR-34 restoration reduced the expression of target genes Bcl-2, Notch, and HMGA2. Bcl-2 3'UTR reporter assay showed that the transfected miR-34s were functional and confirmed that Bcl-2 is a direct target of miR-34. Restoration of miR-34 chemosensitized Kato III cells with a high level of Bcl-2, but not MKN-45 cells with a low level of Bcl-2. miR-34 impaired cell growth, accumulated the cells in G1 phase, increased caspase-3 activation, and, more significantly, inhibited tumorsphere formation and growth. Conclusion Our results demonstrate that in p53-deficient human gastric cancer cells, restoration of functional miR-34 inhibits cell growth and induces chemosensitization and apoptosis, indicating that miR-34 may restore p53 function. Restoration of miR-34 inhibits tumorsphere formation and growth, which is reported to be correlated to the self-renewal of cancer stem cells. The mechanism of miR-34-mediated suppression of self-renewal appears to be related to the direct modulation of downstream targets Bcl-2, Notch, and HMGA2, indicating that miR-34 may be involved in gastric cancer stem cell self-renewal/differentiation decision-making. Our study suggests that restoration of the tumor suppressor miR-34 may provide a novel molecular therapy for p53-mutant gastric cancer.

Abstract A53: Tumor suppressor microRNA miR‐34 inhibits human pancreatic and gastric cancer stem cells

Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres

Effect of Microrna-34a in Cell Cycle, Differentiation, and Apoptosis: A Review

MiR-337 Suppresses Pancreatic Cancer Development Via STAT3/Wnt/β-catenin Axis.

The Effects of Mirnas-107 on Cell Proliferation, Senescence and Invasion of Pancreatic Cancer PANC-1 Cells

MiR-146b-3p regulates proliferation of pancreatic cancer cells with stem cell-like properties by targeting MAP3K10

MicroRNA-216b-5p Functions as a Tumor-suppressive RNA by Targeting TPT1 in Pancreatic Cancer Cells

MicroRNA-34a: a Novel Tumor Suppressor in P53-Mutant Glioma Cell Line U251.

MicroRNA Expression Profiling of Pancreatic Cancer Cell Line L3.6p1 Following B7-H4 Knockdown

P53-induced Mir-1249 Inhibits Tumor Growth, Metastasis, and Angiogenesis by Targeting VEGFA and HMGA2

MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3.

p53/MicroRNA-34 axis in cancer and beyond

Microrna-34a Suppresses the Breast Cancer Stem Cell-Like Characteristics by Downregulating Notch1 Pathway

Restoration of miR-340 controls pancreatic cancer cell CD47 expression to promote macrophage phagocytosis and enhance antitumor immunity

Mir-4666-3p and Mir-329 Synergistically Suppress the Stemness of Colorectal Cancer Cells Via Targeting TGF-β/Smad Pathway

Microrna-873 Inhibits Self-Renewal and Proliferation of Pancreatic Cancer Stem Cells Through Pleckstrin-2-dependent PI3K/AKT Pathway.

Mir-371-5p Facilitates Pancreatic Cancer Cell Proliferation and Decreases Patient Survival

IDDF2018-ABS-0183 P53-induced MIR-1249 suppresses tumour progression by targeting VEGFA and HMGA2 in colorectal cancer

Mir-3656 Expression Enhances the Chemosensitivity of Pancreatic Cancer to Gemcitabine Through Modulation of the RHOF/EMT Axis.

MiR-193a-3p Inhibits Pancreatic Ductal Adenocarcinoma Cell Proliferation by Targeting CCND1.

MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer